UK: The European Patent Office Introduces A "Go-Faster" Opposition Process

The European Patent Office (EPO) has announced that from 1 July 2016, post-grant oppositions will be reformed so that they become significantly faster and more efficient.1 The effect of these changes is that in straightforward cases, the decision in a first instance opposition will be issued within 15 months of the close of the opposition period (which is nine months after the date the European patent was granted).

This is a significant acceleration of the previously notoriously slow opposition procedure. It will be of strategic importance to patentees and their competitors alike, especially against the background of the impending introduction of the Unified Patent Court, and the concerns expressed by national courts in Europe about the significant lack of commercial certainty imposed by the hitherto lengthy EPO opposition procedure.

  • The EPO's pre-July 2016 opposition procedure has been roundly criticised by courts across Europe for its lengthy and open-ended process. "Normal" cases take an average of between four to eight years through to final determination (including appeals). As most European countries stay national litigation pending resolution of an EPO opposition – including the key issue of infringement, which is the exclusive prerogative of the national courts, not the EPO – this can have a chilling effect on business.
  • These reforms demonstrate the EPO's wish to reconfigure its procedures preparatory to the introduction of the Unified Patent Court sometime in 2017, so that the EPO opposition timelines broadly conform with the UPC litigation ones.
  • Patent proprietors and their competitors should now be recalibrating their European patent litigation strategies, including in countries such as England and the Republic of Ireland that do not always stay national litigation pending the result of an EPO opposition. This truncated timeline offers significant strategic opportunities and threats, although it remains to be seen whether the EPO can deliver this faster opposition process, or how easily a determined party can derail it in practice. Nonetheless, these reforms show the EPO as being determined to offer a competing route to central revocation of a European patent, to that offered by the forthcoming Unified Patent Court.
  • While not in itself conclusive, this change in EPO opposition timelines will also change the balance of discretionary factors that the English courts consider when deciding whether or not to order a stay of English national litigation. Broadly, it will be likely to tip the balance towards the grant of a stay. This is because often the most compelling argument in favour of a stay is whether the EPO opposition will finish significantly earlier than, or not much later than, a national trial.

The commercial imperative – the need for certainty and speed Historically, the EPO opposition process is lengthy and drawn out with frequent delays. It can often take between four and eight years before the opposition procedure and all possible appeals are exhausted. The record currently stands at 14 years.2 Even if there is a successful request to accelerate the EPO opposition proceedings because there are pending patent infringement proceedings,3 it can still take up to three years for a final EPO decision (a wait of 15 to 24 months is typical).

The EPO's opposition process has been a victim of its own success. But its delays have attracted significant judicial criticism from national courts. In IPCOM GmbH & Co KG v. HTC Europe Co Limited4 – the leading English case on whether to grant a stay pending resolution of an EPO opposition – Lord Justice Floyd, in giving the unanimous Court of Appeal judgment, held that:

"A procedure which allows disputes over patent rights to take in excess of a decade cannot meet the needs of industry, particularly in rapidly moving areas of technology. Although such a procedure may technically comply with Article 6 of the European Convention on Human Rights, which guarantees a trial before an independent tribunal within a reasonable time, the opportunity for successive appeals and remittals means that there is in practice no final determination of the parties' rights for many years. Given their procedures, the Boards have a difficult task in seeking to achieve justice and finality."

A major concern about EPO oppositions is that while there are clear deadlines for beginning them (they must be launched within nine months of grant), there are no provisions regulating when they must end. One important reason for the drawn-out nature of oppositions is the EPO's serial approach to decision making. Where there are a variety of grounds of opposition, the EPO's practice is to decide the issues in a given order; if a ground succeeds, it is then rare for the Opposition Division (OD) to go on and decide all the other grounds of opposition, as is common in national courts. The inevitable consequence is further delay. If the OD's decision is overturned on appeal, the Technical Board of Appeal will normally have to remit the case back to the OD for it to consider the next issue in the sequence, and so on.

The slow speed of EPO oppositions is particularly troubling for the patentees of patents with shorter life spans. For example, the latest high-tech products are frequently overtaken by more sophisticated alternatives within a few years of appearing on the market, and the value of any corresponding patent rights may be equally short-lived.

The ability to clear the path of third-party rights, or to take swift enforcement action in the early life of a patent, may be critical in fast-moving and competitive industries. Delays of four to six years while the EPO decides whether a patent is valid are not commercially viable. For many companies, a swift decision by a national court may be preferable to achieve some degree of certainty in a key market. A slower but more cost-effective central attack at the EPO can be simultaneously pursued in the hope of achieving a pan-European decision at a later date.

The new procedure in more detail The EPO's streamlined new opposition procedure in effect from 1 July 2016, is intended to simplify opposition proceedings and deliver decisions faster. It is also intended to give the parties more time to react to the summons for oral proceedings, and to prepare for the full opposition hearing.

The principal features of the new procedure are as follows:

  • When filing their formal pleadings, both the opponent and the proprietor must file all relevant documents, even if available in the EPO documentation; translations of any documents not in an EPO official language; and, wherever possible, a copy of any further evidence indicated in them.
  • The parties are obliged to identify in their pleadings the facts, evidence, and arguments they propose to rely on in support of their assertions as to the grounds of opposition.
  • The proprietor's reply is due within four months, and must include any proposed amendments to the patent. The OD will immediately communicate these to the opponent on receipt.
  • The normal period for replying to communications from the OD is four months for communications raising matters of substance and two months for other communications. Extensions of time will only be granted in exceptional cases with duly substantiated requests.
  • If evidence is submitted out of time, the OD will ignore it unless it is of prima facie relevance, i.e., would affect the outcome of the decision to be taken.
  • If oral proceedings are requested by the parties or deemed expedient by the OD, then the date will be fixed when the summons is issued. This date will be not earlier than six months after the summons is sent. At the same time, the OD will set out the issues which it considers must be discussed at the oral proceedings, together with the OD's provisional and non-binding opinion on (i) the positions adopted by the parties, and in particular on (ii) any amendments filed by the proprietor.
  • While the topics dealt with at the oral proceedings are intended to be those specified in writing by the OD, it will not be confined to those issues alone, provided a party's submissions are relevant. But, importantly, if new facts or evidence are submitted for the first time at the oral proceedings, they will be regarded as late-filed and will only be considered if they are of prima facie relevance.

Comment This streamlined opposition procedure is intended to give legal certainty to the parties and the public in a timely and effective manner. While these changes are to be welcomed, it remains to be seen how in practice these reforms will play out and whether they will deliver on the promise of faster justice.

While the desire of the EPO to speed up the opposition procedure should be commended, it appears to be largely at the expense of the patent proprietors. The reduced time to a first instance decision appears in part to be being achieved by limiting the time available for patent proprietors to respond to the opposition. They previously had four months to reply to an opposition, with a two-month extension generally available upon request and additional further extensions often being granted; this will not be the case under the new procedure, where extensions to the initial four-month period will be available only "in exceptional cases with duly substantiated requests". Moreover, there is a notable distinction between the nine months an opponent has to prepare their opposition case and the now four months given to patent proprietors to marshal their fully reasoned and evidenced response to the opposition.

These changes only deal with the first instance part of the opposition process. To that extent, they leave untouched aspects of the overall opposition process which have significant potential to create delay. They do not affect the appeals procedure, which is still governed by the 2007 Rules of Procedure of the Boards of Appeal. Those rules, and the current state of appeal backlogs, mean that most appeal proceedings will continue to add another three or four years to the total opposition procedure time. Nor do they prima facie change the serial nature of EPO decision making, something identified by national courts as a serious cause of delay.

Footnotes

1 EPO Official Journal May 2016, Article A42, 31 May 2016

2 This was the opposition in the Hepatitis B virus litigation between Biogen Inc. and Medeva plc. The judge in the English part of this litigation characterised this delay as "disturbing".

3 See T290/90 SAVIO [1992] OJEPO 368.

4 IPCOM GmbH & Co KG v. HTC Europe Co Limited, Court of Appeal, [2013] EWCA Civ 1496.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.